Miyachi Hideki, Yamamoto Takeshi, Takayama Morimasa, Miyauchi Katsumi, Yamasaki Masao, Tanaka Hiroyuki, Yamashita Jun, Kishi Mikio, Higuchi Satoshi, Abe Kaito, Mase Takaaki, Shinke Toshiro, Yahagi Kazuyuki, Wakabayashi Kohei, Asano Taku, Minatsuki Shun, Saji Mike, Iwata Hiroshi, Mitsuhashi Yuya, Ito Ryosuke, Kondo Seita, Shimizu Wataru, Nagao Ken
Tokyo CCU Network Scientific Committee, Tokyo, Japan.
Division of Cardiovascular Intensive Care, Nippon Medical School Hospital, Tokyo, Japan.
JACC Asia. 2022 Oct 4;2(6):677-688. doi: 10.1016/j.jacasi.2022.06.005. eCollection 2022 Nov.
The mortality rate of acute myocardial infarction (AMI) has improved dramatically because of reperfusion therapy during the last 40 years; however, recent temporal trends for AMI have not been fully clarified in Japan.
The purpose of this study was to elucidate the temporary trend in in-hospital mortality and treatment of AMI for the last decade in the Tokyo Metropolitan area.
We enrolled 30,553 patients from the Tokyo Cardiovascular Care Unit Network Registry, diagnosed with AMI from 2007 to 2016, as part of an ongoing, multicenter, cohort study. We analyzed the temporal trends in basic characteristics, treatment, and in-hospital mortality of AMI.
The overall emergency percutaneous coronary intervention (PCI) rate significantly increased ( < 0.001). In particular, it remarkably increased in patients older than 80 years of age (58.3% to 70.3%, < 0.001) and patients with Killip III or IV (Killip III, 46.9% to 65.7%; Killip IV, 65.2% to 76.6%, < 0.001 for both). The crude and age-adjusted in-hospital mortality remained low (5.2% to 8.2% and 3.4% to 5.5%, respectively) and significantly decreased during the decade ( < 0.001). The in-hospital mortality remarkably decreased in patients older than 80 years of age (17.3% to 12.7%, < 0.001) and in those with cardiogenic shock (38.5% to 27.3%, < 0.001).
This large cohort study from Tokyo revealed that in-hospital mortality of AMI significantly decreased with the increase in emergency percutaneous coronary intervention rate over the decade, particularly for high-risk patients such as older patients and those with cardiogenic shock.
在过去40年中,由于再灌注治疗,急性心肌梗死(AMI)的死亡率已显著改善;然而,日本近期AMI的时间趋势尚未完全明确。
本研究的目的是阐明东京都地区过去十年中AMI患者住院死亡率和治疗的时间趋势。
作为一项正在进行的多中心队列研究的一部分,我们纳入了东京心血管护理单元网络登记处的30553例患者,这些患者在2007年至2016年期间被诊断为AMI。我们分析了AMI患者基本特征、治疗和住院死亡率的时间趋势。
总体急诊经皮冠状动脉介入治疗(PCI)率显著增加(<0.001)。特别是,80岁以上患者(从58.3%增至70.3%,<0.001)以及Killip III或IV级患者(Killip III级,从46.9%增至65.7%;Killip IV级,从65.2%增至76.6%,两者均<0.001)的PCI率显著增加。粗住院死亡率和年龄调整后的住院死亡率仍然较低(分别为5.2%至8.2%和3.4%至5.5%),并且在这十年中显著下降(<0.001)。80岁以上患者(从17.3%降至12.7%,<0.001)以及心源性休克患者(从38.5%降至27.3%,<0.001)的住院死亡率显著下降。
这项来自东京的大型队列研究表明,在过去十年中,随着急诊经皮冠状动脉介入治疗率的增加,AMI患者的住院死亡率显著下降,尤其是对于老年患者和心源性休克患者等高风险患者。